This study assessed the glycaemic and biochemical changes in response to Syzygium
aromaticum administration in diabetic rats. The animals were sampled into 6 groups
of 5 rats each. Group A; control, Group B; diabetic group, Group C; clove only, Group
D-F; clove + alloxan, with concentration of 0.5,1 and 1.5 ml of clove, respectively.
Diabetes was induced in groups B-F. Blood sample was collected via intraocular
puncture weekly for analysis of fasting blood glucose (FBG) level. At the end of 4
weeks, the animals were sacrificed and blood samples taken for estimation of
markers for oxidative stress, lipids and liver function markers. Results were
significant, statistically, at P<0.05. The results showed the diabetic rats exhibited
elevated levels of oxidative stress-induced lipid peroxidation and protein
carbonylation, elevated levels of liver function markers and dyslipidemia. There was
elevated FBG 1 and 2 and HbA1c, indicating poor glycemic control. When compared
to the control, the treatment groups, D, E and F, dose-dependently showed a
reduction in lipid peroxidation and protein carbonylation and significant increase in
the levels of oxidative stress enzyme markers, decrease in ALT and AST levels and
increase in HDL. There was a significant reduction in FBG 2 and HbA1c. The
glycemic and biochemical effect of S. aromaticum may be therapeutically beneficial in
alloxan-induced diabetes in Wistar rats.
Keywords: Diabetes; Hyperglycemia; Cardiovascular; Lipoproteins; Biochemical
